home / stock / myco:cc / myco:cc news

MYCO:CC News and Press, MYDECINE INNOVATIONS GROUP INC. From 07/19/22

Stock Information
Company Name: MYDECINE INNOVATIONS GROUP INC.
Stock Symbol: MYCO:CC
Market: AQNC
Website: mydecine.com
Menu
MYCO:CC MYCO:CC Quote MYCO:CC Short MYCO:CC News MYCO:CC Articles MYCO:CC Message Board
Get MYCO:CC Alerts

News, Short Squeeze, Breakout and More Instantly...
MYCO:CC - InvestorNewsBreaks - Mydecine Innovations Group Inc. (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA) Designs Family of MDMA Analogs, Files Full Patent Application

Mydecine Innovations (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA) , a biotechnology company aiming to transform the treatment of mental health and addiction disorders, has successfully synthesized multiple short-acting MDMA analogs and has filed a patent covering these novel molecules. Experts...
MYCO:CC - Mydecine Files Full Patent Application Covering MYCO-006 Family of Novel Short-Acting MDMA Analogs

DENVER, July 19, 2022 (GLOBE NEWSWIRE) -- Mydecine Innovations Group Inc. (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA) (“Mydecine” or the “Company”), a biotechnology company aiming to transform the treatment of mental health and addiction disorders, announced it has succ...

MYCO:CC - InvestorNewsBreaks - Mydecine Innovations Group (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA) Announces First Clearance of MYCO-001 for Government-Funded Study

Mydecine Innovations (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA) , a biotechnology company aiming to transform the treatment of mental health and addiction disorders, today announced that the U.S. Food and Drug Administration (“FDA”) has cleared MYCO-001 in a recent Investigatio...

MYCO:CC - U.S. FDA Clears MYCO-001 for Multi-Site Government Funded Trial in Smoking Cessation

DENVER, June 17, 2022 (GLOBE NEWSWIRE) -- Mydecine Innovations Group (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA) (“Mydecine” or the “Company”), a biotechnology aiming to transform the treatment of mental health and addiction disorders, today announced that the U.S. Food...
MYCO:CC - InvestorNewsBreaks - Mydecine Innovations Group (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA) Releases Status Update, Announces New Member of the Board

Mydecine Innovations (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA) , a biotechnology company aiming to transform the treatment of mental health and addiction disorders, is sharing key clinical-trial and drug-development updates as well as financial status; the company also appointed a new membe...

MYCO:CC - Mydecine Provides Company Update; Welcomes New Board Member

DENVER, June 09, 2022 (GLOBE NEWSWIRE) -- Mydecine Innovations Group Inc. (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA) (“Mydecine” or the “Company”), a biotechnology company aiming to transform the treatment of mental health and addiction disorders, today provided an upd...

MYCO:CC - Mydecine Announces Closing of Overnight Marketed Public Offering of Units

Mydecine Announces Closing of Overnight Marketed Public Offering of Units Canada NewsWire /NOT FOR DISSEMINATION IN THE UNITED STATES OR THROUGH U.S. NEWSWIRE SERVICES/ DENVER , May 27, 2022 /CNW/ - Mydecine Innovations Group Inc. (" Myd...
MYCO:CC - Mydecine Announces Size of Previously Announced Overnight Marketed Public Offering of Units

Mydecine Announces Size of Previously Announced Overnight Marketed Public Offering of Units Canada NewsWire / NOT FOR DISSEMINATION IN THE UNITED STATES OR THROUGH U.S. NEWSWIRE SERVICES/ DENVER , May 19, 2022 /CNW/ - Mydecine Inno...

MYCO:CC - IIROC Trade Resumption - MYCO

IIROC Trade Resumption - MYCO Canada NewsWire TORONTO , May 19, 2022 /CNW/ - Trading resumes in: Company: MYDECINE INNOVATIONS GROUP INC. NEO Exchange Symbol: MYCO All Issues: Yes Resumption (ET): 8:00 AM IIROC can make a decision to i...

MYCO:CC - Mydecine Overnight Marketed Public Offering of Units

Mydecine Overnight Marketed Public Offering of Units Canada NewsWire /NOT FOR DISSEMINATION IN THE UNITED STATES OR THROUGH U.S. NEWSWIRE SERVICES/ DENVER , May 18, 2022 /CNW/ - Mydecine Innovations Group Inc. (" Mydecine " or the ...
Previous 10 Next 10